Growth Metrics

ENDRA Life Sciences (NDRA) Non-Current Assets (2016 - 2021)

Historic Non-Current Assets for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $844073.0.

  • ENDRA Life Sciences' Non-Current Assets rose 4510.95% to $844073.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $2.8 million, marking a year-over-year increase of 1691.62%. This contributed to the annual value of $557240.0 for FY2020, which is 1309.01% down from last year.
  • Latest data reveals that ENDRA Life Sciences reported Non-Current Assets of $844073.0 as of Q3 2021, which was up 4510.95% from $899592.0 recorded in Q2 2021.
  • ENDRA Life Sciences' Non-Current Assets' 5-year high stood at $899592.0 during Q2 2021, with a 5-year trough of $211345.0 in Q2 2018.
  • Its 5-year average for Non-Current Assets is $446073.9, with a median of $293303.0 in 2018.
  • Its Non-Current Assets has fluctuated over the past 5 years, first plummeted by 2231.82% in 2018, then skyrocketed by 14601.62% in 2020.
  • ENDRA Life Sciences' Non-Current Assets (Quarter) stood at $241549.0 in 2017, then rose by 13.12% to $273233.0 in 2018, then soared by 134.66% to $641170.0 in 2019, then fell by 13.09% to $557240.0 in 2020, then soared by 51.47% to $844073.0 in 2021.
  • Its Non-Current Assets stands at $844073.0 for Q3 2021, versus $899592.0 for Q2 2021 and $547380.0 for Q1 2021.